MLORX | VENAX | MLORX / VENAX | |
Total Expense Ratio | 1.40 | 0.09 | 1,556% |
Annual Report Gross Expense Ratio | 1.80 | 0.09 | 2,000% |
Fund Existence | 11 years | 21 years | - |
Gain YTD | -0.818 | -5.040 | 16% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109M | 8.11B | 1% |
Annual Yield % from dividends | 5.40 | 3.43 | 158% |
Returns for 1 year | -0.41 | -7.77 | 5% |
Returns for 3 years | 13.41 | -6.97 | -192% |
Returns for 5 years | 92.32 | 94.26 | 98% |
Returns for 10 years | 22.93 | 6.27 | 366% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MREGX | 14.72 | N/A | N/A |
BlackRock Unconstrained Equity R | |||
EMGDX | 29.30 | N/A | N/A |
Allspring Emerging Markets Equity R6 | |||
RSLDX | 70.21 | N/A | N/A |
American Funds SMALLCAP World R5E | |||
VYRDX | 15.68 | N/A | N/A |
VY® Columbia Small Cap Value II R6 | |||
RRSRX | 29.95 | -0.05 | -0.17% |
Russell Inv Global Real Estate Secs R6 |